Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO® / DARZALEX® as subcutaneous monotherapy for high-risk smoldering multiple myeloma
-
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES
-
Bloomin’ Brands Announces 2024 Q3 Financial Results
-
Velocity One Signs Merger Agreement with EMCORE (EMKR)
-
SystImmune, Inc. Announces FDA Clearance of IND Application for BL-M17D1 in Advanced Solid Tumors
-
Xeris Biopharma Reports Third Quarter 2024 Financial Results
-
United Homes Group, Inc. Reports 2024 Third Quarter Results
-
Neurotech Provides Update on BLA for NT-501 as a Treatment for Macular Telangiectasia Type 2 (MacTel)
-
Ferraro Foods Partners with Pepper to Launch Mobile-Based Ordering App
-
Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results
-
Kontrol Technologies Announces $2 Million Bitcoin Purchase Plan and Expanding with Data Center Customers
-
Glaukos Announces Participation in Upcoming Investor Conferences
-
Softchoice Announces Third Quarter 2024 Results
-
Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook
-
TEZSPIRE met both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps
-
Clay Cooley Auto Group Expands in Arlington with Acquisition of Don Davis Nissan
-
Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference
-
Pound Sterling Conversion Rate for 2024 Interim Dividend
-
Hippo Reports Third Quarter 2024 Financial Results
-
The international jury of experts for the ninth edition of the Ernesto Illy International Coffee Award has been announced
-
Paying with Crypto Goes Mainstream
-
Assured Guaranty Ltd. Declares Quarterly Dividend of $0.31 per Common Share
-
FDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer
-
Paramount Global Reports Third Quarter Earnings Results
-
Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
-
1stDibs Reports Third Quarter 2024 Financial Results
-
BioXcel Therapeutics to Report Third Quarter 2024 Financial Results on November 14, 2024
-
Fulgent Reports Third Quarter 2024 Financial Results
-
Torram Unveils Groundbreaking Infrastructure Tailored to Usher in a New Era of Bitcoin DeFi
-
NeoGenomics to Participate in the Piper Sandler 36th Annual Healthcare Conference
-
Castle Biosciences to Present New Data Highlighting the Clinical Performance of DecisionDx®-Melanoma and MyPath® Melanoma at the American Society of Dermatopathology 61st Annual Meeting
-
Old Dominion Freight Line Announces Partnership with Folds of Honor
-
CompoSecure Reports Strong Third Quarter 2024 Financial Results
-
Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages PACS Group, Inc. (NYSE: PACS) Investors with losses to Contact the Firm
-
IGM Biosciences Announces Third Quarter 2024 Financial Results and Provides Corporate Update
-
Bright Peak Therapeutics Presents New Data at the 2024 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
-
Onex Corporation Announces Substantial Issuer Bid for up to $400 MILLION of its Subordinate Voting Shares
-
Akero Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Capital Clean Energy Carriers Corp. Announces Third Quarter 2024 Financial Results
-
Torram Unveils Groundbreaking Infrastructure Tailored to Usher in a New Era of Bitcoin DeFi
-
illumin Reports Third Quarter 2024 Financial Results
-
Ashland to host live 2024 strategy update event for analysts and investors
-
Alliance Witan PLC - Net Asset Value
-
Immunocore to present at upcoming investor conferences
-
Perella Weinberg Reports Third Quarter 2024 Results
-
Global Fashion Summit debuts in China, calling for global collaboration on sustainability
-
Brookfield Renewable Announces Record Third Quarter Results
-
ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
-
Material Fact: Guidance 2024 Updated

